|
Michael Berman is a medical device investor/entrepreneur who serves on the boards of 11 emerging companies:
CardiacSense https://www.cardiacsense.com
Cardiosonic http://www.cardiosonic.co.il
ClearCut Medical http://www.clrcut.com
Kedma Solar https://www.kedmasolar.com/?lang=en
QArt Medical https://www.qart-medical.com
STStent www.ststent.com
VenaCore
Mr. Berman was a co-founder of Velocimed which was sold to St. Jude Medical in April, 2005 for $82.5M.
Mr. Berman was a Director of Lutonix from 2007 until 2011 when it was sold to CR Bard for $225M, plus $100M upon FDA approval.
Mr. Berman was a co-founder and Chairman of BridgePoint Medical from 2005 till 2012 when it was sold to Boston Scientific.
Mr. Berman was a co-founder and Chairman of Rebiotix from 2011 till 2018 when it was sold to Ferring Pharmaceuticals.
Mr. Berman was a board member of Mazor Robotics from 2014 till 2018 when it was acquired by Medtronic for $1.7 Billion
Mr. Berman was a director of UltraShape inc. from 2005 till 2011 when it was sold to Syneron.
From 1995-2000 Mr. Berman was the President of the Cardiology business of Boston Scientific.
Cornell University, BS, 1979
Cornell University, MBA, 1986
|
|
|
Contact Information:
Antokolsky 3/315
Tel Aviv, 64044 Israel
Israel Mobile: +972-52-420-3064
USA VOIP : +1-952-512-1523
mikeb@bermanmedical.com
|
|
